This month marks the two-year anniversary of 23andMe’s collaboration with GlaxoSmithKline (GSK).
The agreement gives Almirall the license rights of a bispecific monoclonal antibody that blocks all three isoforms of IL-36 cytokine
Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programs
Anne Wojcicki discusses how 23andMe is becoming a player in medical research for age-old genetic diseases
Xin Fang’s interest in science started at the dinner table, listening to her parents talking about what they did each day. Both her mom and dad are plant scientists. Her mom...
The post Helping to Drive Discovery in 23andMe’s Therapeutics Division appeared first on 23andMe Blog.
Adoptee and filmmaker Aaron Harris used 23andMe to help him learn more about himself, and his connections to his birth family.
The post 23andMe Offers Revelations for Adoptee Searching for His Siblings appeared first on 23andMe Blog.
23andMe released a new 23andMe+ report on gestational diabetes report, which affects an estimated 6 to 9 percent of those expecting. The report looks at a person's ethnicity and more than 6,000 genetic variants associated with developing gestational diabetes mellitus, commonly known as gestational diabetes, during pregnancy.
The post Taking Control for a Healthier Pregnancy appeared first on 23andMe Blog.
23andMe senior scientist in statistical genetics, Suyash Shringarpure, Ph.D. talks about 23andMe's research model and how it offers a surprising opportunity in the study of rare diseases.
The post Talking About Rare Disease with Senior Scientist Suyash Shringarpure appeared first on 23andMe Blog.